You’re unique, your products should be too

Featured Post

Don’t Let Rosacea Get You Down: Treat it With Mirvaso

Rosacea can cause an emotional impact because it can be embarrassing to have constant red skin. Rosacea is a common vascular and inflammatory facial skin condition. People with fair skin over age 30 are more likely to get rosacea, but it can affect people of any age, from any background. Most redheads have beautiful ivory skin and freckles, but once rosacea hits, the beauty is hidden with pounds of makeup.

As if the physical symptoms of rosacea weren’t enough, rosacea can affect your emotional health and well-being as well by causing frustration and worry. In surveys of people with rosacea conducted by the National Rosacea Society:

76% of respondents reported low self-esteem

69% said they were embarrassed by the condition

When a product comes along that is perfect for a redhead, we get so excited to share it with all of you. The first and only FDA-approved treatment specifically developed and indicated for the persistent facial redness of rosacea, MIRVASO® (brimonidine) topical gel, 0.33%*, can help you Break Up With Your Makeup. In clinical trials, people who used Mirvaso saw their redness diminished for up to 12 hours. And for many, redness began to fade quickly—often in as little as 30 minutes. As with any treatment, results can vary. Consulting a physician early on is key to successfully managing rosacea.

Can you imagine a world where you can apply a product which treats rosacea and the redness disappears?! Well, the time has come and you will feel more beautiful than ever before.

Galderma, the makers of Mirvaso, are running an incredibly powerful campaign called, Break Up With Your Makeup. So, let’s stop applying loads of makeup and let Mirvaso help you get red carpet ready. Enter BELOW and you may win a trip to The Emmys in Los Angeles! Redheads, we want to see YOU on the red carpet.

Don’t let rosacea get you down! Embrace your natural skin, give it the love it needs and Rock it like a Redhead.



Important Safety Information
Indication: Mirvaso® topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base. (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist.